Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Planet Labs — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.45 (market cap $6.04B), while Planet Labs trades at $17.32 (market cap $6.25B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Planet Labs are close in size by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Planet Labs for 4 Days on average.
| IOVA | PL | |
|---|---|---|
Market Cap | $6.04B | $6.25B |
Volume | 14,805,993 | 19,125,340 |
Sector | Health | Industrials |
52-Week High | $14.82 | $51.40 |
52-Week Low | $1.81 | $11.16 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $5.97B | $5.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
